David Stroncek

1.1k total citations · 1 hit paper
15 papers, 834 citations indexed

About

David Stroncek is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, David Stroncek has authored 15 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in David Stroncek's work include Immunotherapy and Immune Responses (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and CAR-T cell therapy research (3 papers). David Stroncek is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and CAR-T cell therapy research (3 papers). David Stroncek collaborates with scholars based in United States, Latvia and Canada. David Stroncek's co-authors include Jeffrey McCullough, Jean E. Sanders, E. Donnall Thomas, John A. Hansen, Herbert A. Perkins, Nancy A. Kernan, James Gajewski, Karl G. Blume, Gordon L. Phillips and Patrick G. Beatty and has published in prestigious journals such as New England Journal of Medicine, Blood and Nature Immunology.

In The Last Decade

David Stroncek

15 papers receiving 801 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program

1993 658 citations Nancy A. Kernan, Glenn E. Bartsch et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by David Stroncek

Since Specialization

Citations

This map shows the geographic impact of David Stroncek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stroncek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stroncek more than expected).

Fields of papers citing papers by David Stroncek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Stroncek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stroncek. The network helps show where David Stroncek may publish in the future.

Co-authorship network of co-authors of David Stroncek

This figure shows the co-authorship network connecting the top 25 collaborators of David Stroncek. A scholar is included among the top collaborators of David Stroncek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Stroncek. David Stroncek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	610 Technical challenges in monocyte-derived dendritic cell vaccine manufacturing; a QI project 2020 ·Regular and Young Investigator Award Abstracts ·(unknown), Sandhya R. Panch, (unknown), (unknown), Minh Tran, Steven L. Highfill, (unknown), Ping Jin, (unknown), Malcolm K. Brenner, Jay A. Berzofsky, David Stroncek, Hoyoung Maeng	1
2	At the end of the beginning: immunotherapies as living drugs 2019 ·Nature Immunology ·Ellen G. Feigal, Natalie DeWitt, (unknown), Carl C. Peck, David Stroncek	4
3	Abstract A004: HER2 cancer vaccine phase I clinical trial shows clinical benefit in 54% of evaluable patients 2019 ·Cancer Immunology Research ·Jay A. Berzofsky, Lauren V. Wood, Hoyoung Maeng, Jane B. Trepel, David Stroncek, John C. Morris	1
4	Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse 2016 ·Biology of Blood and Marrow Transplantation ·Nirali N. Shah, David M. Loeb, (unknown), David Stroncek, (unknown), Mark Raffeld, Cindy Delbrook, Crystal L. Mackall, Alan S. Wayne, Terry J. Fry	33
5	Ex Vivo Generation Of CD4+ T Cells To Prevent and Treat Infection From Antibiotic-Resistant Klebsiella Pneumoniae In Immunocompromised Patients 2013 ·Blood ·(unknown), Kong Chen, Dhanalakshmi Chinnasamy, Marianna Sabatino, David Stroncek, Sawa Ito, Tara N. Palmore, Jay K. Kolls, A. John Barrett, Pawel Muranski	1
6	Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome 2011 ·Biology of Blood and Marrow Transplantation ·(unknown), (unknown), (unknown), (unknown), Gerrit Weber, Vicki Fellowes, (unknown), David Stroncek, Susan F. Leitman, Minoo Battiwalla, A. John Barrett	25
7	Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States 2010 ·Blood ·Paul V. O’Donnell, Tanya L. Pedersen, Dennis L. Confer, J. Douglas Rizzo, Michael A. Pulsipher, David Stroncek, Susan F. Leitman, Paolo Anderlini	36
8	Practice Patterns for Evaluation, Consent and Care of Related Donors and Recipients At Hematopoietic Stem Cell Transplant Centers in the United States: Is Conflict-of-Interest an Unrecognized Issue? 2009 ·Biology of Blood and Marrow Transplantation ·Paul V. O’Donnell, Thomas Garm Pedersen, Dennis L. Confer, Michael A. Pulsipher, J. Douglas Rizzo, David Stroncek, Susan F. Leitman, Paolo Anderlini	1
9	Hematopoietic growth factors—use in normal blood and stem cell donors: clinical and ethical issues 2008 ·Transfusion ·Jeffrey McCullough, Jeffrey Kahn, John W. Adamson, Paolo Anderlini, Richard J. Benjamin, Dennis L. Confer, Mary Eapen, Betsy Hirsch, David J. Kuter, (unknown), Derwood Pamphilon, David Stroncek, Jeremy Sugarman, Robert Wilson	18
10	Granulocyte gene polymorphisms and mutations: effects on immune response and neutrophil proliferation 2004 ·Vox Sanguinis ·David Stroncek	2
11	New HLA-A, -B, and -C locus-specific primers for PCR amplification from cDNA: application in clinical immunology 2003 ·Journal of Immunological Methods ·Maria Bettinotti, (unknown), (unknown), (unknown), David Stroncek, Francesco M. Marincola	12
12	High-Resolution HLA-A0201 Subtyping Using Directed Heteroduplex Analysis 1999 ·Journal of Immunotherapy* ·(unknown), (unknown), Kathleen C. Barracchini, Maria Bettinotti, (unknown), Toni B. Simonis, David Stroncek, Francesco M. Marincola	2
13	Mobilization and Transduction of Peripheral Blood Progenitor Cells in Patients with Mucopolysaccharidosis I 1998 ·Journal of Hematotherapy ·Allison Hubel, David Stroncek, Dao Pan, Chester B. Whitley, Jeffrey McCullough	1
14	Proposed policies and procedures for the establishment of a cord blood bank. 1994 ·PubMed ·Jeffrey McCullough, (unknown), Susan K. Fautsch, H. Noreen, Miriam Segall, Elizabeth H. Perry, David Stroncek	39
15	Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program breakdown → 1993 ·New England Journal of Medicine ·Nancy A. Kernan, Glenn E. Bartsch, Robert C. Ash, Patrick G. Beatty, Richard Champlin, Alexandra H. Filipovich, James Gajewski, John A. Hansen, Jean Henslee-Downey, Jeffrey McCullough, Philip B. McGlave, Herbert A. Perkins, Gordon L. Phillips, Jean E. Sanders, David Stroncek, E. Donnall Thomas, Karl G. Blume	658

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact